KLEMA CATHY 4

What Happened Cathy Klema, a director of OptimizeRx Corp (OPRX), was granted 34,517 restricted stock units (RSUs) on June 9, 2026. The Form 4 reports the RSUs at $0.00 per unit (transaction code A — award/grant), so there was no cash purchase or sale in connection with this transaction. The RSUs represent a contingent right to receive shares of OptimizeRx common stock upon vesting.

Key Details

• Transaction date: 2026-06-09; Form filed: 2026-06-10 (timely filing).
• Amount granted: 34,517 RSUs; reported price: $0.00; reported value on Form 4: $0.
• Vesting: The RSUs vest in full on the earlier of the first anniversary of the grant or the Company’s next annual meeting of shareholders (footnote F1).
• Shares owned after transaction: not specified in the provided summary of the Form 4.
• Filing note: The filing includes a standard disclaimer that it is not an admission of beneficial ownership for purposes of Section 16.

Context RSUs are a form of equity compensation that award the right to receive shares in the future if vesting conditions are met; they are not an immediate purchase or sale. Grants to directors are commonly part of routine compensation and do not by themselves indicate the insider’s intent to buy or sell shares. This transaction was an award (not a sale or cash exercise) and was filed promptly.